ArticleChina CDC weekly2025
Mapping the Global Antigenic Evolution of Human Influenza A/H3N2 Neuraminidase Based on a Machine Learning Model - 1968-2024.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Human influenza A/H3N2 imposes a substantial global disease burden. Beyond hemagglutinin (HA), neuraminidase (NA) also plays a critical role in the antigenic evolution of influenza viruses. However, a comprehensive understanding of NA antigenic evolution remains lacking. Methods: NA inhibition (NAI) data were collected and structural epitopes for A/H3N2 NA were identified. A machine learning model was developed to accurately predict antigenic relationships by integrating four feature groups: epitopes, physicochemical properties, N-glycosylation, and catalytic sites. An antigenic correlation network (ACNet) was constructed and antigenic clusters were identified using the Markov clustering algorithm. Results: The best random forest model (PREDEC-N2) achieved an accuracy of 0.904 in cross-validation and 0.867 in independent testing. Eight main antigenic clusters were identified on the ACNet. Spatiotemporal analysis revealed the continuous replacement and rapid global spread of new antigenic clusters for human influenza A/H3N2 NA. Conclusions: This study developed a timely and accurate computational model to map the antigenic landscape of A/H3N2 NA, revealing both its relative antigenic conservation and continuous evolution. These insights provide valuable guidance for improved antigenic surveillance, vaccine recommendations, and prevention and control strategies for human influenza viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.